{
  "main_header": {
    "sid": 622974,
    "name": "Panacea Biotec",
    "stock_name": "Panacea Biotec",
    "full_name": "Panacea Biotec Ltd",
    "name_url": "stocks-analysis/panacea-biotec",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "344.15",
    "chg": -3.05,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "347.20",
    "mcapval": "2,128.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531349,
    "symbol": "PANACEABIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE922B01023",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "44.74 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Panacea Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-panacea-biotec-fallingrising-3742473",
        "imagepath": "",
        "date": "2025-12-03 00:49:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Panacea Biotec’s shares have been under pressure in recent sessions, falling for three consecutive days and losing 4.75% over this period. The stock underperformed its sector by 1.1% on the day, touching an intraday low of ₹351.25, down 3.2%. Notably, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish technical outlook. Investor participation has also waned, with delivery volumes on 01 Dec dropping sharply by 79.01% compared to the five-day average, indicating reduced buying interest from market participants.</p>\n<p><strong>Long-Term Returns and Relative Underperformance</strong></p>\n<p>Over the past year, Panacea Biotec’s stock has deli..."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-bearish-signals-3740124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PanaceaBiotec_technicaldot_3740124.png",
        "date": "2025-12-02 08:07:09",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data and technical indicators reveal nuanced changes in price action and momentum, warranting a closer examination of the stock’s near-term outlook."
      },
      {
        "title": "Panacea Biotec Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3736882",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_mojoScore_3736882.png",
        "date": "2025-11-29 17:52:10",
        "description": "Panacea Biotec has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple analytical parameters, signalling a cautious outlook for investors amid subdued returns and persistent losses."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-mixed-market-signals-3732418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3732418.png",
        "date": "2025-11-27 08:04:19",
        "description": "Panacea Biotec has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. Recent price movements and technical signals provide a nuanced view of the stock’s current position within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Panacea Biotec Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-hits-intraday-high-with-strong-751-surge-on-26-nov-2025-3731540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_priceRelatedfactors_3731540.png",
        "date": "2025-11-26 14:07:45",
        "description": "Panacea Biotec demonstrated robust intraday performance today, surging to an intraday high of Rs 373, marking an 8.41% rise. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and reflected heightened trading activity amid a broadly positive market backdrop."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-bearish-sentiment-3730196",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3730196.png",
        "date": "2025-11-26 08:04:43",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent assessment changes highlight a transition in price momentum and technical indicators, underscoring the challenges faced by the stock amid broader market fluctuations."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-mixed-market-signals-3727523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3727523.png",
        "date": "2025-11-25 08:08:04",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments highlight a transition from bearish to mildly bearish trends. The stock’s price action, supported by a range of technical indicators including MACD, RSI, and moving averages, reveals a complex market assessment that investors should carefully analyse amid broader sector dynamics."
      },
      {
        "title": "Is Panacea Biotec technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-panacea-biotec-technically-bullish-or-bearish-3713868",
        "imagepath": "",
        "date": "2025-11-19 08:14:53",
        "description": "As of 18 November 2025, the technical trend for Panacea Biotec has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish moving averages on the daily timeframe, and a mildly bearish KST on the weekly. The Bollinger Bands indicate a bearish trend on the weekly but are mildly bullish on the monthly, suggesting some divergence. The Dow Theory also supports a mildly bearish outlook on both weekly and monthly timeframes. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market...."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-signal-bearish-outlook-amid-market-pressure-3714264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3714264.png",
        "date": "2025-11-19 08:06:25",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from mildly bearish to bearish trends. The stock’s current price stands at ₹374.50, reflecting a day change of -3.93%, and technical indicators suggest a complex interplay of signals across weekly and monthly timeframes."
      }
    ],
    "total": 191,
    "sid": "622974",
    "stock_news_url": "https://www.marketsmojo.com/news/panacea-biotec-622974"
  },
  "announcements": [
    {
      "details": "Panacea Biotec Limited has informed the Exchange regarding 'Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding publication of Extract of Statement of Unaudited Financial Results for the quarter and half year ended 30.09.2019'.",
      "source": "NSE",
      "caption": "Panacea Biotec Limited - Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Panacea Biotec Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Panacea Biotec Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during October, 2019 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.",
      "source": "NSE",
      "caption": "Panacea Biotec Limited - Updates",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11",
          "dt": "2011-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Panacea Biotec falling/rising?

2025-12-03 00:49:24

Recent Price Movement and Market Performance

Panacea Biotec’s shares have been under pressure in recent sessions, falling for three consecutive days and losing 4.75% over this period. The stock underperformed its sector by 1.1% on the day, touching an intraday low of ₹351.25, down 3.2%. Notably, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish technical outlook. Investor participation has also waned, with delivery volumes on 01 Dec dropping sharply by 79.01% compared to the five-day average, indicating reduced buying interest from market participants.

Long-Term Returns and Relative Underperformance

Over the past year, Panacea Biotec’s stock has deli...

Read More

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:07:09

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data and technical indicators reveal nuanced changes in price action and momentum, warranting a closer examination of the stock’s near-term outlook.

Read More

Panacea Biotec Sees Revision in Market Assessment Amidst Challenging Financials

2025-11-29 17:52:10

Panacea Biotec has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple analytical parameters, signalling a cautious outlook for investors amid subdued returns and persistent losses.

Read More

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-11-27 08:04:19

Panacea Biotec has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. Recent price movements and technical signals provide a nuanced view of the stock’s current position within the Pharmaceuticals & Biotechnology sector.

Read More

Panacea Biotec Hits Intraday High with Strong Trading Momentum

2025-11-26 14:07:45

Panacea Biotec demonstrated robust intraday performance today, surging to an intraday high of Rs 373, marking an 8.41% rise. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and reflected heightened trading activity amid a broadly positive market backdrop.

Read More

Panacea Biotec Technical Momentum Shifts Amid Market Volatility

2025-11-26 08:04:43

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent assessment changes highlight a transition in price momentum and technical indicators, underscoring the challenges faced by the stock amid broader market fluctuations.

Read More

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:08:04

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments highlight a transition from bearish to mildly bearish trends. The stock’s price action, supported by a range of technical indicators including MACD, RSI, and moving averages, reveals a complex market assessment that investors should carefully analyse amid broader sector dynamics.

Read More

Is Panacea Biotec technically bullish or bearish?

2025-11-19 08:14:53

As of 18 November 2025, the technical trend for Panacea Biotec has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish moving averages on the daily timeframe, and a mildly bearish KST on the weekly. The Bollinger Bands indicate a bearish trend on the weekly but are mildly bullish on the monthly, suggesting some divergence. The Dow Theory also supports a mildly bearish outlook on both weekly and monthly timeframes. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market....

Read More

Panacea Biotec Technical Momentum Shifts Amid Bearish Indicators

2025-11-19 08:06:25

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from mildly bearish to bearish trends. The stock’s current price stands at ₹374.50, reflecting a day change of -3.93%, and technical indicators suggest a complex interplay of signals across weekly and monthly timeframes.

Read More

View All News